ENTITY
Progenics Pharmaceuticals

Progenics Pharmaceuticals (PGNX US)

2
Analysis
Health CareUnited States
Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics' principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology.
more
23 Mar 2020 23:05

MergerTalk:Spreads Widen as Covid-19 Spreads Fear -Profitable Opportunities Or Questionable Deals?

As Covid-19 continues to spread far and wide at a rapid pace (at least for now), merger spreads in the US have widened, and in some cases...

Logo
504 Views
Share
bullishS&P 500 INDEX
07 Aug 2018 04:24

U.S. Vital Signs: Actionable Stocks

Key Points: The Staples Sector is leadership and many names are staging price and RS reversals. REIT’s are breaking above bases and are showing RS...

Logo
362 Views
Share
No more insights
x